An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia - Full report

Imagem de Miniatura
Arquivos
art_GRUNDY_An_International_Atherosclerosis_Society_Position_Paper_Global_recommendations_2014.PDF (1.55 MB)
Citações na Scopus
298
Tipo de produção
article
Data de publicação
2014
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
GRUNDY, Scott M.
ARAI, Hidenori
BARTER, Philip
BERSOT, Thomas P.
BETTERIDGE, D. John
CARMENA, Rafael
CUEVAS, Ada
DAVIDSON, Michael H.
GENEST, Jacques
KESANIEMI, Y. Antero
Citação
JOURNAL OF CLINICAL LIPIDOLOGY, v.8, n.1, p.29-60, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
An international panel of the International Atherosclerosis Society has developed a new set of recommendations for the management of dyslipidemia. The panel identifies non high-density lipoprotein cholesterol as the major atherogenic lipoprotein. Primary and secondary prevention are considered separately. Optimal levels for atherogenic lipoproteins are derived for the two forms of prevention. For primary prevention, the recommendations emphasize lifestyle therapies to reduce atherogenic lipoproteins; drug therapy is reserved for subjects at greater risk. Risk assessment is based on estimation of lifetime risk according to differences in baseline population risk in different nations or regions. Secondary prevention emphasizes use of cholesterol-lowering drugs to attain optimal levels of atherogenic lipoproteins.
Palavras-chave
Cholesterol, Dyslipidemia, Lifestyle therapies, Lifetime risk, Metabolic syndrome, Statins
URI
https://observatorio.fm.usp.br/handle/OPI/7434
Referências
  1. Adler AI, 2008, DIABETIC MED, V25, P41, DOI 10.1111/j.1464-5491.2008.02498.x
  2. Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
  3. Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
  4. Allen N, 2012, CIRCULATION, V125, P37, DOI 10.1161/CIRCULATIONAHA.110.002774
  5. Amarenco P, 2006, NEW ENGL J MED, V355, P549
  6. American College of Sports Medicine, 2013, ACSMS GUID EX TEST P
  7. American Diabetes Association, 2012, DIABETES CARE S1, V35, pS11, DOI 10.2337/DC12-S011
  8. ANDERSON KM, 1987, JAMA-J AM MED ASSOC, V257, P2176, DOI 10.1001/jama.257.16.2176
  9. Anderson TJ, 2013, CAN J CARDIOL, V29, P151, DOI 10.1016/j.cjca.2012.11.032
  10. [Anonymous], 2002, CIRCULATION, V106, P3143
  11. Collins R, 2002, LANCET, V360, P7
  12. [Anonymous], 2006, N ENGL J MED, V355, P549
  13. RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351
  14. [Anonymous], 2009, NUTR REV, V67, P114
  15. Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158
  16. Arai H, 2013, J ATHEROSCLER THROMB, V20, P195
  17. Arsenault BJ, 2009, J AM COLL CARDIOL, V55, P35, DOI 10.1016/j.jacc.2009.07.057
  18. Assmann G, 2007, EUR J CLIN INVEST, V37, P925, DOI 10.1111/j.1365-2362.2007.01888.x
  19. Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575
  20. Assmann G, 1996, AM J CARDIOL, V77, P1179, DOI 10.1016/S0002-9149(96)00159-2
  21. AUSTIN MA, 1991, ARTERIOSCLER THROMB, V11, P2
  22. AUSTIN M A, 1988, Journal of the American Medical Association, V260, P1917, DOI 10.1001/jama.260.13.1917
  23. Bader T, 2010, AM J GASTROENTEROL, V105, P978, DOI 10.1038/ajg.2010.102
  24. Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1
  25. Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3
  26. Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5
  27. Ballantyne CM, 2008, J AM COLL CARDIOL, V52, P626, DOI 10.1016/j.jacc.2008.04.052
  28. Ballantyne CM, 2013, AM J CARDIOL, V111, P506, DOI 10.1016/j.amjcard.2012.10.037
  29. Banel DK, 2009, AM J CLIN NUTR, V90, P56, DOI 10.3945/ajcn.2009.27457
  30. Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278
  31. Barter P, 2011, ATHEROSCLEROSIS SUPP, V12, P267, DOI 10.1016/S1567-5688(11)70885-6
  32. Barter PJ, 2006, J INTERN MED, V259, P247, DOI 10.1111/j.1365-2796.2006.0161.x
  33. Barylski M, 2013, PHARMACOL RES, V72, P35, DOI 10.1016/j.phrs.2013.03.007
  34. Barzi F, 2007, J EPIDEMIOL COMMUN H, V61, P115, DOI 10.1136/jech.2005.044842
  35. Baum SJ, 2012, J CLIN LIPIDOL, V6, P216, DOI 10.1016/j.jacl.2012.04.077
  36. Bays HE, 2013, J CLIN LIPIDOL, V7, P304, DOI 10.1016/j.jacl.2013.04.001
  37. Bays HE, 2001, CLIN THER, V23, P1209, DOI 10.1016/S0149-2918(01)80102-8
  38. Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848
  39. Bhalodkar NC, 2006, AM J CARDIOL, V97, P1007, DOI 10.1016/j.amjcard.2005.10.036
  40. Bittner V, 2009, AM HEART J, V157, P548, DOI 10.1016/j.ahj.2008.11.014
  41. BLACKBURN H, 1987, CIRCULATION, V76, P164
  42. Blair SN, 2000, AM J CARDIOL, V86, P46, DOI 10.1016/S0002-9149(00)00976-0
  43. Blake GJ, 2002, CIRCULATION, V106, P1930, DOI 10.1161/01.CIR.0000033222.75187.B9
  44. Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579
  45. Boekholdt SM, 2012, JAMA-J AM MED ASSOC, V307, P1302, DOI 10.1001/jama.2012.366
  46. Bonow RO, 2002, CIRCULATION, V106, P1602, DOI 10.1161/01.CIR.0000035036.22612.2B
  47. Brindle P, 2003, BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267
  48. Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090
  49. Brown L, 1999, AM J CLIN NUTR, V69, P30
  50. Brown MS, 2006, SCIENCE, V311, P1721, DOI 10.1126/science.1125884
  51. BROWN MS, 1976, NEW ENGL J MED, V294, P1386
  52. Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z
  53. Budoff MJ, 1996, CIRCULATION, V93, P898
  54. Bukkapatnam Radhika N, 2010, Prev Cardiol, V13, P84, DOI 10.1111/j.1751-7141.2009.00059.x
  55. Campbell TC, 1998, AM J CARDIOL, V82, p18T
  56. Canner PL, 2005, AM J CARDIOL, V95, P254, DOI 10.1016/j.amjcard.2004.09.013
  57. CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245
  58. Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583
  59. Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070
  60. Cannon CP, 2008, AM HEART J, V156, P826, DOI 10.1016/j.ahj.2008.07.023
  61. Cannon CP, 2005, JAMA-J AM MED ASSOC, V294, P2492, DOI 10.1001/jama.294.19.2492
  62. Casas JP, 2008, J INTERN MED, V264, P295, DOI 10.1111/j.1365-2796.2008.02015.x
  63. Castelli W P, 1992, Ann Epidemiol, V2, P23
  64. Catapano AL, 2011, ATHEROSCLEROSIS, V217, P3, DOI 10.1016/j.atherosclerosis.2011.06.028
  65. Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112
  66. Chow CK, 2009, J EPIDEMIOL COMMUN H, V63, P379, DOI 10.1136/jech.2008.077057
  67. CHUNG BH, 1994, ARTERIOSCLER THROMB, V14, P622
  68. Civeira F, 2004, ATHEROSCLEROSIS, V173, P55, DOI 10.1016/j.atherosclerosis.2003.11.010
  69. ClinicalTrials.gov, HPS II THRIVE
  70. Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013
  71. Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5
  72. Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4181
  73. Cook NR, 2012, CIRCULATION, V125, P1748, DOI 10.1161/CIRCULATIONAHA.111.075929
  74. Correll CU, 2006, J CLIN PSYCHIAT, V67, P575
  75. Corsetti JP, 2004, ATHEROSCLEROSIS, V177, P367, DOI 10.1016/j.atherosclerosis.2004.07.019
  76. Cui YD, 2001, ARCH INTERN MED, V161, P1413, DOI 10.1001/archinte.161.11.1413
  77. D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180
  78. Daniels SR, 2011, J CLIN LIPIDOL, V5, pS30, DOI 10.1016/j.jacl.2011.03.453
  79. Davidson MH, 2011, J CLIN LIPIDOL, V5, P338, DOI 10.1016/j.jacl.2011.07.005
  80. Davignon J, 2012, BRIT J CLIN PHARMACO, V73, P518, DOI 10.1111/j.1365-2125.2011.04139.x
  81. Dayton S, 1969, CIRCULATION S2, V40, pII1
  82. De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6
  83. de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307
  84. Hawthorne V, 2002, HEART, V88, P222
  85. Domanski M, 2011, NAT REV CARDIOL, V8, P721, DOI 10.1038/nrcardio.2011.158
  86. Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615
  87. Eichler K, 2007, AM HEART J, V153, P722, DOI 10.1016/j.ajh.2007.02.027
  88. Elam M, 2011, CURR OPIN LIPIDOL, V22, P55, DOI 10.1097/MOL.0b013e328341a5a8
  89. Elias-Smale SE, 2010, J AM COLL CARDIOL, V56, P1407, DOI 10.1016/j.jacc.2010.06.029
  90. Elley CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052145
  91. Empana JP, 2003, EUR HEART J, V24, P1903, DOI 10.1016/j.ehj.2003.09.002
  92. ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196
  93. Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303
  94. Matsuzawa Y, 2002, CIRC J, V66, P987
  95. Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
  96. Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6
  97. Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411
  98. Farwell WR, 2005, AM J CARDIOL, V96, P1129, DOI 10.1016/j.amjcard.2005.06.044
  99. Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017
  100. Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333
  101. Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061
  102. Franco OH, 2009, CIRCULATION, V120, P1943, DOI 10.1161/CIRCULATIONAHA.109.855817
  103. Fraser GE, 2009, AM J CLIN NUTR, V89, pS1607, DOI 10.3945/ajcn.2009.26736K
  104. FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001
  105. FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499
  106. Fruchart JC, 2008, AM J CARDIOL, V102, p1K, DOI 10.1016/S0002-9149(08)01833-X
  107. Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736
  108. Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032
  109. Gardner CD, 1996, JAMA-J AM MED ASSOC, V276, P875, DOI 10.1001/jama.276.11.875
  110. Gasevic D, 2012, METABOLISM, V61, P583, DOI 10.1016/j.metabol.2011.09.009
  111. Genest J, 2003, CAN MED ASSOC J, V169, P921
  112. Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282
  113. Goldberg AC, 2011, J CLIN LIPIDOL, V5, P133, DOI 10.1016/j.jacl.2011.03.001
  114. Goldberg RB, 2012, ARTERIOSCL THROM VAS, V32, P2077, DOI 10.1161/ATVBAHA.111.241893
  115. Goldstein JL, 2001, METABOLIC MOL BASES, VIII, P2863
  116. Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004
  117. GORDON DJ, 1989, CIRCULATION, V79, P8
  118. GORDON DJ, 1995, LOWERING CHOLESTEROL, P333
  119. Graham I, 2007, ATHEROSCLEROSIS, V194, P1, DOI 10.1016/j.atherosclerosis.2007.08.024
  120. Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425
  121. Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210
  122. Grundy Scott M, 2006, Nat Rev Drug Discov, V5, P295, DOI 10.1038/nrd2005
  123. GRUNDY SM, 1986, NEW ENGL J MED, V314, P745, DOI 10.1056/NEJM198603203141204
  124. Grundy SM, 2007, J CLIN ENDOCR METAB, V92, P399, DOI 10.1210/jc.2006-0513
  125. Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092
  126. Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
  127. Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
  128. GRUNDY SM, 1969, J LIPID RES, V10, P304
  129. Grundy SM, 1999, AM J CARDIOL, V83, P1455
  130. GRUNDY SM, 1990, EUR HEART J, V11, P462
  131. Grundy SM, 2011, AM J CARDIOL, V108, P40, DOI 10.1016/j.amjcard.2011.03.003
  132. Guerci AD, 1997, AM J CARDIOL, V79, P128
  133. Gylling H, 1999, METABOLISM, V48, P575, DOI 10.1016/S0026-0495(99)90053-7
  134. Hadaegh F, 2009, NUTR METAB CARDIOVAS, V19, P401, DOI 10.1016/j.numecd.2008.09.003
  135. Hara K, 2006, DIABETES CARE, V29, P1123, DOI 10.2337/dc05-2540
  136. Havel RJ, 2000, CURR OPIN LIPIDOL, V11, P615, DOI 10.1097/00041433-200012000-00008
  137. Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055
  138. Hayward RA, 2010, ANN INTERN MED, V152, P69, DOI 10.7326/0003-4819-152-2-201001190-00004
  139. Hayward RA, 2006, ANN INTERN MED, V145, P520
  140. Hayward RA, 2012, CIRC-CARDIOVASC QUAL, V5, P2, DOI 10.1161/CIRCOUTCOMES.111.964676
  141. Health Canada, 2003, 2003 PUBL, V4645
  142. Hense HW, 2003, EUR HEART J, V24, P937, DOI 10.1016/S0195-668X(03)00081-2
  143. Hippisley-Cox J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6624
  144. Hippisley-Cox J, 2008, BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25
  145. Hoang KC, 2008, DIABETES CARE, V31, P1405, DOI 10.2337/dc07-2087
  146. Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0
  147. Holme I, 2008, J INTERN MED, V264, P30, DOI 10.1111/j.1365-2796.2008.01925.x
  148. Hou WY, 2013, EUR HEART J, V34, P1807, DOI 10.1093/eurheartj/eht065
  149. HUBERT HB, 1983, CIRCULATION, V67, P968
  150. Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0
  151. Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI [10.2337/dc12-0413, 10.2337/dc12-041.3]
  152. Iso H, 2001, AM J EPIDEMIOL, V153, P490, DOI 10.1093/aje/153.5.490
  153. Jaumdally JR, 2006, CURR PHARM DESIGN, V12, P1611, DOI 10.2174/138161206776843331
  154. Jelesoff Nicole E, 2006, Endocr Pract, V12, P159
  155. Jellinger Paul S, 2012, Endocr Pract, V18 Suppl 1, P1
  156. JENKINS DJA, 1993, NEW ENGL J MED, V329, P21, DOI 10.1056/NEJM199307013290104
  157. Jenkins DJA, 2000, CURR OPIN LIPIDOL, V11, P49, DOI 10.1097/00041433-200002000-00008
  158. Jeppesen J, 1998, CIRCULATION, V97, P1029
  159. Jiang R, 2004, DIABETES CARE, V27, P1991, DOI 10.2337/diacare.27.8.1991
  160. Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3
  161. Kang HT, 2012, NUTR METAB CARDIOVAS, V22, P1054, DOI 10.1016/j.numecd.2011.01.013
  162. Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477
  163. Karmali KN, 2013, NAT REV CARDIOL, V10, P111, DOI 10.1038/nrcardio.2012.185
  164. Kastelein JJP, 2008, CIRCULATION, V117, P3002, DOI 10.1161/CIRCULATIONAHA.107.713438
  165. Katan MB, 2003, MAYO CLIN PROC, V78, P965
  166. Kathiresan S, 2006, CIRCULATION, V113, P20, DOI 10.1161/CIRCULATINAHA.105.567107
  167. Kathiresan S, 2008, NEW ENGL J MED, V358, P2299, DOI 10.1056/NEJMc0707445
  168. Kendrick Malcolm, 2007, BMJ, V334, P983, DOI 10.1136/bmj.39202.397488.AD
  169. KEYS A, 1984, PREV MED, V13, P141, DOI 10.1016/0091-7435(84)90047-1
  170. Keys A, 1980, 7 COUNTRIES MULTIVAR
  171. Khan NA, 2006, CAN J CARDIOL, V22, P583
  172. Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433
  173. Knowler WC, 2002, NEW ENGL J MED, V346, P393
  174. Kok FJ, 2004, EUR J NUTR, V43, P2, DOI 10.1007/s00394-004-1102-x
  175. Kris-Etherton PN, 2008, J NUTR, V138, p1746S
  176. Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603
  177. Kromhout D, 2000, INT J EPIDEMIOL, V29, P260, DOI 10.1093/ije/29.2.260
  178. Krumholz HM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3531
  179. Kuller L, 2002, ARTERIOSCL THROM VAS, V22, P1175, DOI 10.1161/01.ATV.0000022015.97341.3A
  180. Lamarche B, 1996, CIRCULATION, V94, P273
  181. LaRosa JC, 2007, AM J CARDIOL, V100, P747, DOI 10.1016/j.amjcard.2007.03.102
  182. LaRosa JC, 2013, AM J CARDIOL, V111, P1221, DOI 10.1016/j.amjcard.2012.12.052
  183. LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461
  184. LAURIER D, 1994, J CLIN EPIDEMIOL, V47, P1353, DOI 10.1016/0895-4356(94)90079-5
  185. LAW MR, 1994, BRIT MED J, V308, P367
  186. Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423
  187. Ledford H, 2013, NATURE, V494, P410, DOI 10.1038/494410a
  188. Lee M, 2011, ATHEROSCLEROSIS, V217, P492, DOI 10.1016/j.atherosclerosis.2011.04.020
  189. Lewis SJ, 1998, ANN INTERN MED, V129, P681
  190. Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391
  191. Liao YL, 1999, AM HEART J, V137, P837, DOI 10.1016/S0002-8703(99)70407-2
  192. Tonkin A, 1998, NEW ENGL J MED, V339, P1349
  193. Liu J, 2006, AM J CARDIOL, V98, P1363, DOI 10.1016/j.amjcard.2006.06.032
  194. Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591
  195. Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9
  196. Lloyd-Jones DM, 2007, AM J CARDIOL, V99, P535, DOI 10.1016/j.amjcard.2006.09.099
  197. Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703
  198. Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206
  199. Lloyd-Jones DM, 2004, AM J CARDIOL, V94, P20, DOI 10.1016/j.amjcard.2004.03.023
  200. Lloyd-Lones DM, 2003, ARCH INTERN MED, V163, P1966, DOI 10.1001/archinte.163.16.1966
  201. Lonn E, 2010, CIRCULATION, V122, P2078, DOI 10.1161/CIRCULATIONAHA.109.873232
  202. Lorenzo C, 2007, DIABETES CARE, V30, P8, DOI 10.2337/dc06-1414
  203. Ma S, 2011, CYTOKINE GROWTH F R, V22, P167, DOI 10.1016/j.cytogfr.2011.05.004
  204. Marma AK, 2010, CIRC-CARDIOVASC QUAL, V3, P8, DOI 10.1161/CIRCOUTCOMES.109.869727
  205. Marques-Vidal P, 2009, INT J CARDIOL, V133, P346, DOI 10.1016/j.ijcard.2008.01.004
  206. Marrugat J, 2003, J EPIDEMIOL COMMUN H, V57, P634, DOI 10.1136/jech.57.8.634
  207. Mascitelli L, 2012, LANCET, V380, P1816, DOI 10.1016/S0140-6736(12)62025-X
  208. McKenney JM, 2006, AM J CARDIOL, V97, p89C, DOI 10.1016/j.amjcard.2006.02.030
  209. McLaughlin T, 2003, ANN INTERN MED, V139, P802
  210. Mendis S, 2011, GLOBAL ATLAS CARDIOV
  211. Menotti A, 2000, EUR HEART J, V21, P365, DOI 10.1053/euhj.1999.1864
  212. MENOTTI A, 1993, EUR J EPIDEMIOL, V9, P527
  213. Menotti A, 2008, EUR J CARDIOV PREV R, V15, P719, DOI 10.1097/HJR.0b013e328315789c
  214. Mensink RP, 2003, AM J CLIN NUTR, V77, P1146
  215. MIETTINE.M, 1972, LANCET, V2, P835
  216. MIETTINEN TA, 1995, NEW ENGL J MED, V333, P1308, DOI 10.1056/NEJM199511163332002
  217. Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5
  218. Milhos CG, 2010, CARDIOL REV, V18, P298
  219. Misra A, 2009, J Assoc Physicians India, V57, P163
  220. Mora S, 2010, CIRCULATION, V121, P1069, DOI 10.1161/CIRCULATIONAHA.109.906479
  221. Moss AJ, 1999, CIRCULATION, V99, P2517
  222. Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034
  223. Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735
  224. Murphy MJ, 2013, JAMA INTERN MED, V173, P162, DOI 10.1001/2013.jamainternmed.477
  225. Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075
  226. National Institute for Health and Clinical Excellence The National Collaborating Centre for Primary Care, 2008, NIC CLIN GUID, V71
  227. National Institutes of Health, 1998, OBES RES, V6, P464
  228. National Institutes of Health, 1998, OBES RES S2, V6, p51S
  229. Newman DH, 2012, LANCET, V380, P1814, DOI 10.1016/S0140-6736(12)62020-0
  230. Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386
  231. O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3
  232. Oka R, 2008, DIABETES RES CLIN PR, V79, P474, DOI 10.1016/j.diabres.2007.10.016
  233. Okwuosa TM, 2011, J AM COLL CARDIOL, V57, P1838, DOI 10.1016/j.jacc.2010.11.053
  234. O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103
  235. Orchard TJ, 2005, ANN INTERN MED, V142, P611
  236. Orchard TJ, 2006, DIABETES CARE, V29, P2528, DOI 10.2337/dc06-1161
  237. Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537
  238. Park YS, 2012, J KOREAN MED SCI, V27, P243, DOI 10.3346/jkms.2012.27.3.243
  239. Parker BA, 2013, CIRCULATION, V127, P96, DOI 10.1161/CIRCULATIONAHA.112.136101
  240. Pasternak RC, 2002, J AM COLL CARDIOL, V40, P567, DOI 10.1016/S0735-1097(02)02030-2
  241. Patt MR, 2003, OBES RES, V11, P660, DOI 10.1038/oby.2003.94
  242. Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437
  243. Pelletier P, 2009, CAN J CARDIOL, V25, pE413
  244. Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694
  245. Pencina MJ, 2007, AM J EPIDEMIOL, V165, P464, DOI 10.1093/aje/kwk025
  246. IRVING S, 1992, CIRCULATION, V85, P1083
  247. Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092
  248. Pietinen P, 2001, J Nutr Health Aging, V5, P150
  249. Pietinen P, 1996, PREV MED, V25, P243, DOI 10.1006/pmed.1996.0053
  250. Polonsky TS, 2012, LANCET, V380, P783, DOI 10.1016/S0140-6736(12)60772-7
  251. Pooling Project Research Group, 1978, J CHRON DIS, V31, P201
  252. Porter KE, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001931
  253. Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860
  254. Ramjee V, 2011, J AM COLL CARDIOL, V58, P457, DOI 10.1016/j.jacc.2011.05.009
  255. Ramsay SE, 2011, EUR J CARDIOV PREV R, V18, P186, DOI 10.1177/1741826710389394
  256. RAPP JH, 1994, ARTERIOSCLER THROMB, V14, P1767
  257. Ray KK, 2005, J AM COLL CARDIOL, V46, P1405, DOI 10.1016/j.jacc.2005.03.077
  258. Ridker PM, 2007, J AM COLL CARDIOL, V49, P2129, DOI 10.1016/j.jacc.2007.02.052
  259. Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326
  260. Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646
  261. Robinson JG, 2009, J AM COLL CARDIOL, V53, P316, DOI 10.1016/j.jacc.2008.10.024
  262. Robinson JG, 2012, AM J CARDIOL, V110, P1468, DOI 10.1016/j.amjcard.2012.07.007
  263. Rodgers A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019857
  264. Rodondi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034287
  265. Rojas-Fernandez CH, 2012, ANN PHARMACOTHER, V46, P549, DOI 10.1345/aph.1Q620
  266. Ros E, 2013, CIRCULATION, V128, P553, DOI 10.1161/CIRCULATIONAHA.112.001119
  267. Rosenbaum D, 2013, NUTR METAB CARDIOVAS, V23, P871, DOI 10.1016/j.numecd.2012.04.012
  268. Rosenson RS, 2002, AM J CARDIOL, V90, P89, DOI 10.1016/S0002-9149(02)02427-X
  269. ROSSOUW JE, 1990, NEW ENGL J MED, V323, P1112, DOI 10.1056/NEJM199010183231606
  270. Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604
  271. RUMBERGER JA, 1994, AM J CARDIOL, V73, P1169, DOI 10.1016/0002-9149(94)90176-7
  272. RUMBERGER JA, 1995, CIRCULATION, V92, P2157
  273. Sabate J, 2010, ARCH INTERN MED, V170, P821, DOI 10.1001/archinternmed.2010.79
  274. Sachdeva A, 2009, AM HEART J, V157, P111, DOI 10.1016/j.ahj.2008.08.010
  275. Sacks FM, 2000, CIRCULATION, V102, P1893
  276. Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6
  277. PEDERSEN TR, 1994, LANCET, V344, P1383
  278. Schmermund A, 1998, J AM COLL CARDIOL, V31, P1267, DOI 10.1016/S0735-1097(98)00082-5
  279. Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711
  280. Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215
  281. Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0
  282. Shai I, 2004, CIRCULATION, V110, P2824, DOI 10.1161/01.CIR.0000146339.57154.9B
  283. Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X
  284. SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001
  285. Singh RB, 2000, J HUM HYPERTENS, V14, P749, DOI 10.1038/sj.jhh.1001057
  286. Skyler JS, 2009, DIABETES CARE, V32, P187, DOI 10.2337/dc08-9026
  287. Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d
  288. Sniderman A, 2010, CURR OPIN LIPIDOL, V21, P518, DOI 10.1097/MOL.0b013e32833ee80c
  289. Sniderman AD, 2011, CIRC-CARDIOVASC QUAL, V4, P337, DOI 10.1161/CIRCOUTCOMES.110.959247
  290. Sniderman AD, 2012, ATHEROSCLEROSIS, V225, P444, DOI 10.1016/j.atherosclerosis.2012.08.039
  291. Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673
  292. Solano MP, 2006, CLIN DIABETES, V24, P27, DOI 10.2337/diaclin.24.1.27
  293. STAMLER J, 1982, BIOMETRICS, V38, P95, DOI 10.2307/2529859
  294. STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823
  295. Stefanutti C, 2013, ATHEROSCLEROSIS SUPP, V14, P19, DOI 10.1016/j.atherosclerosissup.2012.10.021
  296. Steinberg D, 2012, J AM COLL CARDIOL, V60, P2640, DOI 10.1016/j.jacc.2012.09.016
  297. Stone NJ, 2013, CIRCULATION
  298. St-Pierre AC, 2005, ARTERIOSCL THROM VAS, V25, P553, DOI 10.1161/01.ATV.0000154144.73236.f4
  299. St-Pierre AC, 2001, CIRCULATION, V104, P2295, DOI 10.1161/hc4401.098490
  300. Sung J, 2008, CORONARY ARTERY DIS, V19, P475, DOI 10.1097/MCA.0b013e3283078f9f
  301. Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890
  302. Talmud PJ, 2002, ARTERIOSCL THROM VAS, V22, P1918, DOI 10.1161/01.ATV.0000035521.22199.C7
  303. Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D
  304. Teramoto T, 2007, J ATHEROSCLER THROMB, V14, P45
  305. Gerstein HC, 2008, NEW ENGL J MED, V358, P2545
  306. Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859
  307. Thompson A, 2010, LANCET, V375, P1536
  308. Thompson GR, 2010, CURR OPIN LIPIDOL, V21, P487, DOI 10.1097/MOL.0b013e32833e13fd
  309. Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681
  310. Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77
  311. Thomsen TF, 2001, J CARDIOVASC RISK, V8, P291, DOI 10.1097/00043798-200110000-00008
  312. Tonelli M, 2012, LANCET, V380, P807, DOI 10.1016/S0140-6736(12)60572-8
  313. Tota-Maharaj R, 2012, EUR HEART J, V33, P2955, DOI 10.1093/eurheartj/ehs230
  314. Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
  315. Twickler ThB, 2005, Curr Atheroscler Rep, V7, P140, DOI 10.1007/s11883-005-0037-x
  316. U-King-Im JM, 2009, LANCET NEUROL, V8, P569, DOI 10.1016/S1474-4422(09)70092-4
  317. van den Brandt PA, 2011, AM J CLIN NUTR, V94, P913, DOI 10.3945/ajcn.110.008250
  318. Vanhees L, 2012, EUR J PREV CARDIOL, V19, P1005, DOI 10.1177/1741826711430926
  319. Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026
  320. Veniant MM, 2000, J CLIN INVEST, V106, P1501, DOI 10.1172/JCI10695
  321. Wagstaff LR, 2003, PHARMACOTHERAPY, V23, P871, DOI 10.1592/phco.23.7.871.32720
  322. Wald DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041297
  323. Wald NJ, 2003, BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419
  324. Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2
  325. Walsh JME, 2004, JAMA-J AM MED ASSOC, V291, P2243, DOI 10.1001/jama.291.18.2243
  326. Wang J, 2012, ATHEROSCLEROSIS, V220, P102, DOI 10.1016/j.atherosclerosis.2011.10.032
  327. Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644
  328. Wannamethee SG, 2011, ARCH INTERN MED, V171, P404, DOI 10.1001/archinternmed.2011.2
  329. Wannamethee SG, 2008, INT J OBESITY, V32, pS25, DOI 10.1038/ijo.2008.32
  330. Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545
  331. Wardlaw JM, 2009, STROKE, V40, P3511, DOI 10.1161/STROKEAHA.109.557017
  332. Watts GF, 2011, ATHEROSCLEROSIS SUPP, V12, P221, DOI 10.1016/j.atherosclerosissup.2011.06.001
  333. WHO, 2000, WHO TECHN REP SER, V894
  334. Wiesbauer F, 2009, EUR HEART J, V30, P1073, DOI 10.1093/eurheartj/ehp051
  335. Wilkins JT, 2012, JAMA-J AM MED ASSOC, V308, P1795, DOI 10.1001/jama.2012.14312
  336. Wilson PWF, 2008, CIRC-CARDIOVASC QUAL, V1, P92, DOI 10.1161/CIRCOUTCOMES.108.831198
  337. WOLF RN, 1983, ARTERIOSCLEROSIS, V3, P160
  338. World Health Organization, TOBACCO
  339. Yeboah J, 2013, EUR J PREV CARDIOL
  340. Yokokawa H, 2011, J ATHEROSCLER THROMB, V18, P89
  341. Teramoto Tamio, 2013, J Atheroscler Thromb, V20, P517
  342. Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3
  343. Youssef George, 2013, Curr Cardiol Rep, V15, P325, DOI 10.1007/s11886-012-0325-3
  344. Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9
  345. Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5
  346. Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605
  347. Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/InCor